trial · primary record
Cryopreserved Autologous CD34+ cells transduced with pCCLCHIM-p47
p47
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 10 |
| Primary completion | 2027-03-31 |
| Primary endpoint | To evaluate the efficacy of pCCLCHIM-p47 transduced autologous CD34+ cells treatment in p47 AR-CGD patients as measured by engraftment of genetically modified cells. |
| Registry ID | NCT06253507 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:52.958Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06253507
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.